The drug was launched in single-dose infusion bags in the US market
Dr Reddy’s Laboratories (DRL) has launched Levetiracetram in Sodium Chloride Injection, 500 mg/100 mL (5 mg/mL), 1,000 mg/100 mL (10 mg/mL), and 1,500 mg/100 mL (15 mg/mL) single-dose infusion bags, a therapeutic equivalent generic version of HQ Specialty Pharma Corporation’s Levetiracetam in Sodium Chloride Injection, approved by the US Food and Drug Administration (US FDA).
The Levetiracetam in Sodium Chloride Injection brand and generic had US sales of approximately $37 million MAT for the most recent twelve months ending in April 2018 according to IMS Health.
DRL Levetiracetam in Sodium Chloride Injection is available in strengths of 500 mg/100 mL (5 mg/mL), 1,000 mg/100 mL (10 mg/mL), and 1,500 mg/100 mL (15 mg/mL) single-dose infusion bags.
Comments are closed.